The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients

Vincent Probst(Centre National de la Recherche Scientifique), Hervé Le Marec(Centre National de la Recherche Scientifique), Béatrice Guyomarch(Centre Hospitalier Universitaire de Nantes), Dominique Babuty(Université de Tours), Jacques Mansourati(Université de Bretagne Occidentale), Gilles Lande(Inserm), D. Plassard-Kerdoncuf(Inserm), F. Sacher(Hôpital Cardiologique du Haut-Lévêque), P. Mabo(Hôpital Pontchaillou), Christine Fruchet(Inserm)
EP Europace
March 21, 2011
10.1093/europace/eur060
Cited by 38

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
|Nature|2003|961
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
|EP Europace|2011|904
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome
|Circulation|2010|850
Cardiac conduction defects associate with mutations in SCN5A
|Nature Genetics|1999|638